117 related articles for article (PubMed ID: 7685864)
21. Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA).
Slikker W; Ali SF; Scallet AC; Frith CH; Newport GD; Bailey JR
Toxicol Appl Pharmacol; 1988 Jul; 94(3):448-57. PubMed ID: 2456631
[TBL] [Abstract][Full Text] [Related]
22. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats.
Mokler DJ; Robinson SE; Rosecrans JA
Eur J Pharmacol; 1987 Jun; 138(2):265-8. PubMed ID: 2887440
[TBL] [Abstract][Full Text] [Related]
23. 3,4-Methylenedioxymethamphetamine, serotonin and memory.
Ricaurte GA; Markowska AL; Wenk GL; Hatzidimitriou G; Wlos J; Olton DS
J Pharmacol Exp Ther; 1993 Aug; 266(2):1097-105. PubMed ID: 8102642
[TBL] [Abstract][Full Text] [Related]
24. Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) exposure induces long-term alterations in the dopaminergic and serotonergic functions in the rat.
Galineau L; Belzung C; Kodas E; Bodard S; Guilloteau D; Chalon S
Brain Res Dev Brain Res; 2005 Feb; 154(2):165-76. PubMed ID: 15707670
[TBL] [Abstract][Full Text] [Related]
25. Reduction of in vivo binding of [3H]paroxetine in mouse brain by 3,4-methylenedioxymethamphetamine.
Hashimoto K; Goromaru T
Neuropharmacology; 1990 Jul; 29(7):633-9. PubMed ID: 1696701
[TBL] [Abstract][Full Text] [Related]
26. Chlormethiazole, dizocilpine and haloperidol prevent the degeneration of serotonergic nerve terminals induced by administration of MDMA ('Ecstasy') to rats.
Hewitt KE; Green AR
Neuropharmacology; 1994 Dec; 33(12):1589-95. PubMed ID: 7539115
[TBL] [Abstract][Full Text] [Related]
27. Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine injury: observations in rats.
Scanzello CR; Hatzidimitriou G; Martello AL; Katz JL; Ricaurte GA
J Pharmacol Exp Ther; 1993 Mar; 264(3):1484-91. PubMed ID: 7680719
[TBL] [Abstract][Full Text] [Related]
28. The effect of 5-HT receptor ligands on the uptake of [3H]5-hydroxytryptamine into rat cortical synaptosomes.
Cheng CH; Costall B; Naylor RJ; Rudd JA
Eur J Pharmacol; 1993 Aug; 239(1-3):211-4. PubMed ID: 8223895
[TBL] [Abstract][Full Text] [Related]
29. N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy').
Baumann MH; Clark RD; Budzynski AG; Partilla JS; Blough BE; Rothman RB
Neuropsychopharmacology; 2005 Mar; 30(3):550-60. PubMed ID: 15496938
[TBL] [Abstract][Full Text] [Related]
30. p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro.
Gobbi M; Moia M; Pirona L; Ceglia I; Reyes-Parada M; Scorza C; Mennini T
J Neurochem; 2002 Sep; 82(6):1435-43. PubMed ID: 12354291
[TBL] [Abstract][Full Text] [Related]
31. Effect of combined administration of 5-HT1A or 5-HT1B/1D receptor antagonists and antidepressants in the forced swimming test.
Tatarczyńska E; Kłodzińska A; Stachowicz K; Chojnacka-Wójcik E
Eur J Pharmacol; 2004 Mar; 487(1-3):133-42. PubMed ID: 15033385
[TBL] [Abstract][Full Text] [Related]
32. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
Callaway CW; Wing LL; Geyer MA
J Pharmacol Exp Ther; 1990 Aug; 254(2):456-64. PubMed ID: 1974635
[TBL] [Abstract][Full Text] [Related]
33. Inhibition by tetanus toxin of sodium-dependent, high-affinity [3H]5-hydroxytryptamine uptake in rat synaptosomes.
Inserte J; Najib A; Pelliccioni P; Gil C; Aguilera J
Biochem Pharmacol; 1999 Jan; 57(1):111-20. PubMed ID: 9920291
[TBL] [Abstract][Full Text] [Related]
34. Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine isomers on central serotonergic, dopaminergic and nigral neurotensin systems of the rat.
Johnson M; Letter AA; Merchant K; Hanson GR; Gibb JW
J Pharmacol Exp Ther; 1988 Mar; 244(3):977-82. PubMed ID: 2472482
[TBL] [Abstract][Full Text] [Related]
35. MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.
Battaglia G; Yeh SY; De Souza EB
Pharmacol Biochem Behav; 1988 Feb; 29(2):269-74. PubMed ID: 2452449
[TBL] [Abstract][Full Text] [Related]
36. The effects of repeated administration of MDMA on the expression of sexual behavior in the male rat.
Dornan WA; Katz JL; Ricaurte GA
Pharmacol Biochem Behav; 1991 Jul; 39(3):813-6. PubMed ID: 1723802
[TBL] [Abstract][Full Text] [Related]
37. The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine.
Berger UV; Gu XF; Azmitia EC
Eur J Pharmacol; 1992 May; 215(2-3):153-60. PubMed ID: 1356787
[TBL] [Abstract][Full Text] [Related]
38. MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal raphe neurons in brain slices via release of serotonin.
Sprouse JS; Bradberry CW; Roth RH; Aghajanian GK
Eur J Pharmacol; 1989 Aug; 167(3):375-83. PubMed ID: 2572435
[TBL] [Abstract][Full Text] [Related]
39. The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain.
Stone DM; Stahl DC; Hanson GR; Gibb JW
Eur J Pharmacol; 1986 Aug; 128(1-2):41-8. PubMed ID: 2875893
[TBL] [Abstract][Full Text] [Related]
40. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.
Colado MI; Williams JL; Green AR
Br J Pharmacol; 1995 Aug; 115(7):1281-9. PubMed ID: 7582557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
